Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Techniques of Therapeutic Communication II: Focusing, Paraphrasing, and Summarizing01:23

Techniques of Therapeutic Communication II: Focusing, Paraphrasing, and Summarizing

7.8K
Focusing involves centering a conversation on a message's critical elements or concepts. Focusing is valuable if the talk is vague or patients begin to repeat themselves. Sometimes, when patients are asked about their symptoms, they may go off-topic and try to tell their entire life story. Respectfully, the nurse should bring the conversation back into focus.
This therapeutic technique can also be used when a patient brings up pertinent information during a health-related conversation. The...
7.8K
Dementia01:30

Dementia

113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
113
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive Rehabilitation and Functional Outcomes in Long COVID-Related Cognitive Impairment: A Randomized Clinical Trial.

JAMA network open·2026
Same author

The ENIGMA-PD-WML Pipeline: A Containerized, User-Friendly Approach for Accurate, Standardized Segmentation of White Matter Lesions in Multi-Site MRI Data.

bioRxiv : the preprint server for biology·2026
Same author

Use of Wearable Technology for Measuring and Characterizing Sedentary Behavior in People With Mild Cognitive Impairment and Dementia: Systematic Review.

JMIR aging·2026
Same author

Personalised prediction of institutionalisation in Parkinson's: prognostic factor identification and model development and validation using IPD meta-analysis.

Parkinsonism & related disorders·2026
Same author

When the Scale Drops: Pathways to Weight Loss in Parkinson's Disease and Future Directions.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Improving Advance Care Planning for People with Parkinson's.

Movement disorders clinical practice·2026
Same journal

Correction to "Advancing Neuromodulation for Functional Movement Disorders: A Contemporary Narrative Review of Evidence, Gaps, and Future Outlook".

Movement disorders clinical practice·2026
Same journal

Efficacy of IncobotulinumtoxinA (BoNT-A) Injections in Upper Limb Task-Specific and Position-Dependent Tremors.

Movement disorders clinical practice·2026
Same journal

Health-Related Quality of Life in Children with Primary Complex Motor Stereotypies.

Movement disorders clinical practice·2026
Same journal

7 T MRI Connectivity-Guided Reprogramming Improves Deep Brain Stimulation Motor Outcome in Parkinson's Disease.

Movement disorders clinical practice·2026
Same journal

Cutis Verticis Gyrata in SPG11-Related Hereditary Spastic Paraplegia: A Potential Novel Association.

Movement disorders clinical practice·2026
Same journal

"Familial Is Not Always Genetic: Two Brothers with Dystonia and Oculomotor Apraxia Secondary to Rh Incompatibility-Induced Kernicterus".

Movement disorders clinical practice·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2025

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

1.6K

Improving Conversations about Parkinson's Dementia.

Ivelina Dobreva1, Joanne Thomas2, Anne Marr3

  • 1Dementia Research Centre, Queen Square Institute of Neurology, University College London, Russell Square House, London, United Kingdom.

Movement Disorders Clinical Practice
|May 2, 2024
PubMed
Summary
This summary is machine-generated.

Open conversations about Parkinson's disease (PD) dementia are crucial. Co-produced resources aim to improve communication between patients, caregivers, and clinicians, addressing stigma and encouraging proactive care for PD dementia.

Keywords:
Parkinson'sParkinson's dementia

More Related Videos

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

25.6K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K

Related Experiment Videos

Last Updated: Jun 27, 2025

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

1.6K
Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

25.6K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K

Area of Science:

  • Neurology
  • Geriatrics
  • Psychiatry

Background:

  • Parkinson's disease (PD) significantly increases dementia risk.
  • Stigma and misconceptions hinder open discussion of PD dementia.
  • Improved communication can lead to better support, treatment access, and research participation.

Purpose of the Study:

  • To co-produce accessible information resources.
  • To enhance conversations about Parkinson's disease dementia (PD dementia).
  • To involve patients, caregivers, and healthcare professionals in resource development.

Main Methods:

  • Creative workshops involving people with PD, caregivers, and experts.
  • Collaborative development of information resources.
  • Incorporation of insights from 34 participants and 25 PD experts.

Main Results:

  • Most individuals with PD (70%) and caregivers (81%) worried about cognitive changes.
  • Few had discussed these concerns with healthcare professionals (38% PD, 30% caregivers).
  • High agreement (91% PD, 73% caregivers) for routine cognitive assessments by clinicians.
  • Co-developed open-access resources for patients, families, and healthcare professionals.

Conclusions:

  • Creative workshops facilitated co-production of valuable resources.
  • Diverse voices and co-learning improved resource relevance.
  • Enhanced communication strategies for PD dementia were developed.